Lag-3 is involved in maintaining the tolerogenic state of CD8 T cells in models of self and tumor tolerance and synergizes with PD-1 in maintaining CD8 exhaustion during chronic viral infection [22], [23]. The gene discussed is CD8A; the disease is neoplasm.